How We Manage Patient Expectations

by Jack Lewin November 18, 2009 01:36

On Monday I attended a plenary about managing patient expectations in the face of the current cost-savings-focused environment. As doctors, we sometimes find that patients want the most expensive care or the most tests as part of their treatment because they view it as the “best” care they can receive. However, this usually isn’t true. The best care is the care that’s been validated by science – and high quality science at that. This can be difficult to come by, even in the field of cardiology, which compared to other specialties, has some of the best research available.

Why does cardiology have some of the best, most comprehensive research? Because cardiology has registries, and we use them to collect data in real-life, which we then turn into the research that informs the clinical documents that guide everyday practice. The ACC has a suite of six registries (NCDR) that together pull research from nearly 2,000 hospitals and 180 practices (yes, one of those registries is an ambulatory registry – the PINNACLE Registry -- formerly called the IC3 Program).

At AHA, research from the NCDR is making quite an appearance. There’s a total of 14 abstracts from the NCDR out at AHA, which hopefully you had the opportunity to check out: five abstracts from the CathPCI Registry; four from the ICD Registry, one from the CARE Registry, two from ACTION®-GWTG™ and two from the IC3 Program (now the PINNACLE Registry).

Of particular excitement are the two abstracts from ACC’s IC3 Program/PINNACLE Registry. The first is an oral presentation by Paul S. Chan, M.D., M.P.H., on “A Report of the First 10,000+ Patients.” The study found nearly three in five enrolled patients had coronary artery disease (CAD) and all the outpatient performance measures (PMs) could reliably be assessed. Adherence to the CAD PMs was often suboptimal, suggesting substantial opportunity for improving the quality of outpatient care.

The second (a poster presentation by ACC staff members Kristi Mitchell, M.P.H., and Sunil Gupte, Ph.D.) is “Electronic Medical Record Adoption in Cardiology Practices: A 2009 Snapshot.” This study found EMR adoption within PINNACLE Registry (then the IC3 Program) is slightly greater than that reported in the literature and may be due to the greater number of large practices enrolled. The PINNACLE Registry provides a foundation to analyze EMR adoption and implementation rates in U.S. cardiology practices and to observe trends associated with reducing some of the financial barriers due to the recent provision of federal funding. As such, the PINNACLE Registry will be positioned to determine the impact of EMR usage on clinical quality and patient outcomes.

The large number of abstracts presented at the meeting is a testament to the rich evidence coming from these groundbreaking registries. We need to keep moving forward with our efforts so that ALL clinical decisions can be made on the basis of the strongest level of evidence.

UPDATED: 11/19 with video.

AHA Daily Wrap Up: Monday

by Jack Lewin November 17, 2009 03:54

Some good trials came out yesterday at AHA. Here's the wrap up.

AHA Daily Wrap Up: Sunday

by Jack Lewin November 16, 2009 04:07

Here is Sunday's daily wrap up from CVN of LBCTs at AHA.

Kudos to KP and the Archimedes Program

by Jack Lewin October 22, 2009 09:35

Kaiser Permanente’s CEO George Halvorson called for a celebration this month for the successes of a program launched decades ago they call Archimedes. It is a computerized artificial intelligence system that creates models of the human body and then projects the probable impact of care and treatment approaches. Archimedes has been used to do a couple of clinical trials and ended up with results that matched the actual clinical trials done on live patients. They routinely use it to improve care. And it works.

One of their primo researchers, David Eddy, M.D., just did a large scale test of Archimedes relative to the prevention of heart attacks and strokes. One of the scenarios that the researchers ran through Archimedes looked at what might happen when a mixture of prescriptions that science has suggested are helpful in CAD was combined to prevent heart attacks and strokes. (The drugs considered were aspirin, Lisinopril, and a statin). There was no tool to do that study. So they used Archimedes and ran a computer experiment with their own patient database.

Archimedes predicted that a "bundled" prescription of heart protective medications would reduce the risk of heart attack and stroke for the Kaiser Permanente high-risk populations by 71 percent. They missed by a bit. Over the course of three years, the three drug program actually prevented 1,271 heart attacks and strokes. That reduced the occurrence of heart attacks and strokes for the covered population by 60 percent instead of the 71 percent projected by the system.

300 media outlets have picked up this story. The world now knows that the simple combination of medications in KP's Aspirin-Lisinopril-Lovastatin (A-L-L) initiative -- this will have a potentially greater impact on emerging nations that can’t afford interventions I suspect. It’s very interesting stuff. And, they’re spreading the option to participate across their entire population, and 250,000 have signed up to try it with disease management and/or early risk factors.

It’s impressive -- they’re using predictive modeling, targeted member outreach, and computer-supported care to get real results. Hats off to KP and Archimedes.

*** Image info: http://www.flickr.com/photos/gi/ / CC BY-SA 2.

Take a Deep Breath ...

by Jack Lewin September 23, 2009 09:20

... or not. A study released by the American Heart Association shows that even tiny amounts of air pollution and cigarette smoke can dramatically increase your risk for cardiovascular disease. Researchers from Brigham Young University analyzed data from more than 1 million adults, noting smoking habits and exposure to secondhand smoke and air pollution. Their findings suggest breathing in far less than one cigarette a day worth of smoke increases your risk of cardiovascular disease by 20 percent to 30 percent. Wow. We all need a breath of fresh air.

Meanwhile, two new studies -- one in the Journal of the American College of Cardiology and one in AHA's Circulation -- publishing Sept. 29 found that smoking bans cut heart attacks by 17 percent and that this effect increases over time. (See CardioSmart for more coverage of these studies.)

It was amazing being in Spain at ESC -- there is smoking everywhere, and it’s very obnoxious in restaurants and public areas. We’ve made a lot of progress in these regards, but more is needed.

*** Image from Flickr (SuperFantastic). *** 

ESC Daily Wrap Up Monday

by Jack Lewin September 1, 2009 03:32

Even more impressive science out of the ESC meeting. Peter Block, F.A.C.C., and Chris Cannon, F.A.C.C., from CVN have more on ISAR TEST 4, TIMI 38 and TRIANA trials, and complete coverage is available from Cardiosource.

Tags: ,

ESC 09 Daily Wrap Up Sunday

by Jack Lewin August 31, 2009 04:35

The science so far at ESC 09 has been quite impressive. Check out Sunday's daily wrap-up video from CVN, featuring RE LY, PLATO and CURRENT OASIS 7.

Tags: ,

Friday Poll: Are you attending ESC Congress 2009?

by Jack Lewin August 28, 2009 08:09

Beginning tomorrow, I’m off for several days to the beautiful city of Barcelona for ESC (European Society of Cardiology) Congress 2009. I’ll be covering the event daily, so check back for updates. Also, follow the ACC on Twitter for more scientific coverage (@Cardiosource) and general news (@ACCinTouch) from the meeting.

Check out this preview video from Cardiosource:

 

There's not always robust evidence, Mr. President: Other ways to fill the clinical void [GUEST POST]

by Jack Lewin June 24, 2009 02:37

This month’s post comes to us from Robert Hendel, M.D., F.A.C.C., chair of the Cardiac Radionuclide Imaging Writing Group, member of the Appropriate Use Criteria Task Force AND chair of the Evaluation and Implementation of Appropriate Use Criteria. As you can see, Dr. Hendel has quite the interest in improving quality. He also led the way in demonstrating the effectiveness of appropriate use criteria to reduce inappropriate testing when he released the results of a pilot with UnitedHealthCare on SPECT MPI.

**********************************************

President Obama’s speech to the American Medical Association last week has been the topic of much discussion within the health care community. While outlining many components of his vision for health care reform, his emphasis on quality care resonated with me, largely due to the ACC’s continuing focus on this area. As the President stated, “…the bulk of our costs is the nature of our health care system itself – a system where we spend vast amounts of money on things that aren't making our people any healthier; a system that automatically equates more expensive care with better care.”

Unfortunately, cardiology was specifically mentioned in a less than flattering fashion, when he cited the recent JAMA publication that found only half of all cardiac guidelines are based on scientific evidence.

Improving Care through Clinical Documents
However, this conclusion is misleading with regards to the value of practice guidelines and the overall aim of providing the best care. Not every clinical scenario has robust literature support and in its absence, expert consensus opinion must fill the void to assist cardiologists in decision-making. The ACC, in conjunction with the American Heart Association and many subspecialty organizations, has been a leader in the medical world in developing documents to guide clinicians. Through practice guidelines, performance measures and appropriate use criteria, the College has been instrumental in improving cardiovascular care.

Beyond documents that define optimal, “must do” therapeutics, such as performance measures, clinicians need guidance in selecting the right test for the right patient at the right time. Since the inception of appropriate use criteria, which seek to define what test or procedure would be reasonable to perform for a given clinical situation, there has been a growing acceptance of this approach. The appropriate use criteria movement has been carefully followed by the Centers for Medicare and Medicaid Services (CMS) and private health plans, receiving almost universal praise.

Because of their basis on a strict, well-accepted methodology and that they are continually modified to provide contemporary application for resource utilization and reimbursement, appropriate use criteria have been recognized by national quality organizations. The most recent criteria, which are a revision of the radionuclide imaging criteria originally published in 2005, now have closed many of the gaps in the criteria’s application and are based largely on patient care flow diagrams. Other appropriate use criteria documents are now being revised and a multimodality approach to imaging criteria is underway in conjunction with the American College of Radiology.

Implementation, Evaluation
While creating these documents is very important, the ACC also is committed to the implementation and evaluation of appropriate use criteria, a critical component to actually affecting health care. In March, I presented the results of the multicenter pilot examination of the SPECT [Single Photon Emission Computed Tomography] Appropriate Use Criteria done in partnership with United HealthCare, which revealed the feasibility of applying the criteria to improve care. The pilot also was helpful in identifying areas of improvement in the use of SPECT.

CMS now has begun planning for a $10 million demonstration project testing appropriate use criteria and has involved ACC directly in the dialog. Furthermore, appropriateness is now a key focus of national medical quality organization, like the National Committee on Quality Assurance, AQA Alliance and others.

Physicians as Quality Drivers
We, as cardiologists, along with our representative organization, the ACC, must not lose momentum. We have to continue to drive the process from the physician perspective, with emphasis on quality and patient access. If we lose our focus, we risk having external forces, such as radiology benefits management companies, dictate the practice of cardiology. While the realigning of incentives to encourage quality is clearly needed, we must also do all we can right now to ensure that our patients receive the highest quality of cardiovascular care by using clinical documents to guide care choices.

- By Robert Hendel, M.D., F.A.C.C.

* Dr. Hendel's post is part of a monthly series of guest posts by ACC leadership. Check back next month to see which ACC leader is sharing his or her thoughts on health care reform!  

Are We Exporting Innovation?

by Jack Lewin June 13, 2009 11:28
Tony DeMaria, M.A.C.C., our JACC editor in chief, recently used his May 19 Editor’s Page to discuss the alarming frequency with which initial clinical trials for novel devices and therapies are being performed outside of the U.S. According to Dr. DeMaria, the situation "clearly raise[s] a question as to whether we in America are exploiting the rest of the world to prematurely test potentially hazardous therapies, or conversely, whether our regulatory and financial environment is stifling access to important new innovations for patients and investigators."

The piece has generated a high volume of responses. “It seems to have struck a chord,” Dr. DeMaria says. One reader notes, “Over the past two decades I have seen an unfortunate gap develop between U.S. and overseas investigations, making us in effect second-tier investigators within the international community. Devices we have invented end up being evaluated, approved and used in general practice well ahead of us ... Percutaneous valves are one the latest example of this dangerous trend/gap!”

I applaud his message. We need to turn this around. Read Dr. DeMaria’s Editor’s Page here. But having just returned from India this week, and after visiting a most amazing 1000 bed CV hospital in Bangalore that produces outcomes comparable to the US (be ready to be stunned) for about 10 % of the cost, I think we need to be aware of the astounding and frankly positive growth of research outside the US that is developing exponentially. One thing the emerging world has going for them is that in environments with no insurance or health care coverage, experimental and novel therapies can be tested in willing patients far more prevalently that in the US or Europe. This will result in a great deal more relevant manuscripts, and in application of new therapies in early stages of illness, that will be considered here only as “compassionate use” therapy in late stages of disease, and only after traditional therapy fails. They will be able to see if new therapy works when started before the patient is near terminal. We won’t. And, as health reform in the US ratchets down the screws on PHARMA, they will go abroad to innovate, taking jobs with them. I’m just trying to cheer everybody up here…

Committed to Comparative Effectiveness

by Jack Lewin April 21, 2009 09:29

UPDATE: The ACC has released this statement on our committment to comparative effectiveness, in response to a recent Bloomberg article on a new coalition called the Partnership for Improving Patient Care, an organization formed to promote comparative effectiveness and comparative effectiveness research (see yesterday's post on the subject "Clinical and Cost Effectiveness: The Bloomberg Boo Boo). It states:

We must develop much-needed randomized clinical trial data to fill many research gaps in the current environment. CE and CER provide a critical means to address these data and research inadequacies. Without a multi-billion dollar ongoing commitment to comparative effectiveness through federal funding, many unanswered vital clinical questions could persist for decades. This is unacceptable.

The College fully understands that cost effectiveness also is important to society and to health care reform and that it is an important parallel process to clinical effectiveness. If we are to distribute scarce resources fairly to the most important scientific and clinical priorities and to all patients regardless of income, we must determine cost effectiveness of care options, once the science is clear, and recognize that marginal increases in clinical effectiveness with very large price tags will not be affordable in a sustainable health system.

It concludes: "There’s no conspiracy here. ACC’s participation in PIPC is consistent with our principles, policies, commitment to ethics and appropriate relationships with industry."

Clinical and Cost Effectiveness: The Bloomberg Boo Boo

by Jack Lewin April 20, 2009 03:20

Bloomberg News this week reported a damning story on a new organization called the Partnership for Improving Patient Care (PIPC). PIPC is a benign and positive new coalition (about 4 months old), which industry folks have decided to participate in.

The Bloomberg story suggests PIPC is nothing more than a front for big PhRMA, and actually opposes comparative effectiveness. Wrong. ACC joined PIPC about two months ago (for a nominal membership fee) to be part of a very broad constituency of consumer groups, professional societies and others who believe that comparative clinical effectiveness is a critical priority in health care reform, as well as a process that must be determined in a scientific, unbiased and pure fashion -- and thus not mixed up with cost effectiveness as the hidden goal -- in order to have the respect and trust of physicians and patients.

Other members of this partnership include the American Association of People with Disabilities, American Academy of Nursing, the American Association of Neurological Surgeons, the Association of Clinical Research Organizations, Easter Seals, the National Alliance for Hispanic Health, the AIDS Institute and many more. Some pharmaceutical companies, device manufacturers and related coalitions have recently also joined to support the aforementioned goals. That shouldn’t be surprising. More...

Just When You Thought It Was Safe to Get Back in the Water ...

by Jack Lewin April 17, 2009 10:15

You probably noticed that one of the studies presented at this year’s Annual Scientific Session showed sudden deaths occurred nearly twice as often in athletes participating in triathlons as in athletes participating in marathons: 1.5 per 100,000 versus 0.8 per 100,000. Investigators examined deaths that occurred in 2,846 triathlons featuring 922,810 participants. Nearly all the triathlon sudden deaths took place during the swimming portion of the event. 

Noting this unexpected differential, I've asked ACC Board members and officers to stick to marathons from now on.

*** Image from Flickr (Diamondduste). ***

Tags: ,

Forget Disney World – Orlando is the Home of ACC.09

by Jack Lewin March 29, 2009 04:20

This is it, folks. The event you’ve been waiting for all year -- ACC.09, of course. The science is at an all-time groundbreaking level, attendance is high and the education simply can’t be beat. This year’s meeting will focus on quality, quality and more quality in cardiovascular practice.

We started this morning with the the ACC.09 Scientific Showcase, featuring the Simon Dack Lecture by Princeton University economics professor Uwe Reinhardt, a presidential address by ACC President Doug Weaver, M.D., F.A.C.C., and a JUPITER trial presentation. Reinhardt discussed the challenges facing the health care system and its stakeholders, while Dr. Weaver discussed the challenges facing the cardiology profession.

Starting a little after noon, noted health care economist Len Nichols will present the 48th Annual Louis Bishop lecture on “What Health Care Reform Will Cost Us: And Why Doing Nothing Will Cost Us Even More.”  Nichols, who spoke at our 2009 Health System Reform Summit, will discuss the problems with the health care system and its payment structure. The health care system can’t afford “business as usual” and something must change. Following his presentation, president-elect Fred Bove, M.D., F.A.C.C., immediate past president, Jim Dove, M.D., M.A.C.C., and past president Tim Garson, M.D., M.A.C.C., and I will discuss the implications of and chances for health care reform.

Reform isn’t going to be easy, but we’ve got to do it. If we can just implement some of the ideas from Reinhardt and Nichols, we’ll be well on our way.

*** Image from Flickr (Stacy Young) ***

We're. Almost. There.

by Jack Lewin March 25, 2009 07:27

In a mere three days, the cardiology world will head to Orlando for ACC.09 – the best place to find the latest and most innovative findings in CV science. If you’re a cardiovascular practitioner, the conference will provide opportunities to interact with experts from around the world and discuss approaches to clinical dilemmas. Our motto – “Helping Cardiovascular Professionals Learn. Advance. Heal.” – is something we take very seriously around here, and ACC.09 is just one way in which we fulfill it. Check out the ACC.09 Web site for a great video about the meeting: http://acc09.acc.org

Science isn’t the only thing that’s going to be new in Orlando – the ACC is launching its most robust foray into social media ever, by combining the blog with other social media like Twitter and Flickr, to connect and share at ACC.09.

Here’s how you can get connected (Feel a bit old and out of it? I’ve included links to FAQs so you can figure out exactly what I’m talking about): 

  • Continue to follow the blog – this should go without saying!
  • Sign up for Twitter, a real-time messaging service (first FAQ here). ACC has two accounts for members, ACC_09 and Cardiology, available here and here. If you become a follower of ACC_09 on Twitter, you’ll be kept up-to-date on breaking news, events and interesting tidbits about the meeting. You’ll also be able to connect with other ACC_09 followers and discuss meeting highlights.
  • Upload your photos to the ACC09 group on Flickr, a photo sharing Web site (second FAQ here), available at http://www.flickr.com/groups/acc_09, or by searching ACC09.

As you can see, ACC.09 is an event not to be missed. We hope to see you at ACC.09 – online and off!

Powered by BlogEngine.NET 1.4.5.0
Theme by Mads Kristensen

Share your Story: Proposed 2010 Physician Fee Schedule

Read more about the Proposed 2010 Physician Fee Schedule and share your thoughts. How would the cuts impact the way you practice medicine?

About the author

Jack Lewin has been chief executive office of the American College of Cardiology since November 2006. Under his leadership the College has continued to build upon its standing as a national leader in advocacy, with a particular focus on reforming Medicare, Medicaid, and the financing and delivery of quality health care. Learn more about Dr. Lewin.


Recent Comments

Comment RSS

Calendar

<<  November 2009  >>
MoTuWeThFrSaSu
2627282930311
2345678
9101112131415
16171819202122
23242526272829
30123456

View posts in large calendar